AVAVA Named Winner Best Emerging Disruptor Octane High Tech AwardsInnovative Focal Point Technology™ with ComfortCool™ Delivers Regenerative Aesthetic Treatments Safe for all Skin Tones—Redefining Skin Health from the Inside Out
MULTIMEDIA UPDATE: AVAVA™ Receives FDA Clearance for Revolutionary Acne Scar Treatment using Focal Point Technology™BOSTON, April 22, 2025 (GLOBE NEWSWIRE) -- AVAVA™, a medical aesthetics innovation company redefining energy-based skin therapy, announced today that its advanced acne scar treatment using Focal Point Technology™ has received clearance from the U.S. Food and Drug Administration (FDA). This clinical indication affirms the platform’s ability to treat acne scarring effectively with high energies in all Fitzpatrick skin types (I–VI).
AVAVA™ Receives FDA Clearance for Revolutionary Acne Scar Treatment using Focal Point Technology™BOSTON, April 22, 2025 (GLOBE NEWSWIRE) -- AVAVA™, a medical aesthetics innovation company redefining energy-based skin therapy, announced today that its advanced acne scar treatment using Focal Point Technology™ has received clearance from the U.S. Food and Drug Administration (FDA). This clinical indication affirms the platform’s ability to treat acne scarring effectively with high energies in all Fitzpatrick skin types (I–VI).
Leading Laser Medicine Expert Dr. Rox Anderson Joins AVAVA™ Board of DirectorsWALTHAM, Mass., Jan. 30, 2025 (GLOBE NEWSWIRE) -- AVAVA™, a leader in the aesthetic energy device market, proudly announces the appointment of Dr. Rox Anderson, co-founder of AVAVA, to its Board of Directors. Widely regarded as a trailblazer in dermatology and laser medicine, Dr. Anderson’s expertise will play a pivotal role in shaping AVAVA’s future as it continues to revolutionize energy-based technologies for all skin types.
AVAVA™ Announces Industry Heavyweights Clint Carnell as Executive Chairman and Mary Fisher to Its Board of Directors
AVAVA™, a leader in transformative energy-based technology, today announced the appointment of Clint Carnell as Executive Chairman of the Board and Mary Fisher to its Board of Directors. These distinguished industry veterans bring a wealth of experience in scaling high-growth companies, reinforcing AVAVA's commitment to accelerated expansion and increased market share in the medical aesthetics sector.
Medical Aesthetics Company AVAVA Secures $35 Million in Financing to Support Commercial Expansion of Breakthrough Laser Technology
AVAVA, Inc., an innovative medical aesthetics platform company advancing a new class of image-guided, focused intradermal laser products that are safe and effective for all skin tones, today announced that it secured $35 million in new financing.
AVAVA Receives FDA 510(k) Clearance for its First-in-Class High Energy Skin Renewal Platform – MIRIA Skin Treatment SystemWALTHAM, Mass., Dec. 07, 2022 (GLOBE NEWSWIRE) -- AVAVA Inc. (“AVAVA” or the “Company”), a disruptive medical aesthetics platform company advancing a new class of focused intradermal laser products for breakthrough treatments of all skin tones, today announced that its MIRIA Skin Treatment System (“MIRIA system”) has received FDA 510(k) clearance for prevention (pre-rejuvenation) and treatment (rejuvenation) of skin aging. This marks a first of its kind regulatory clearance for a high energy focused intradermal laser, powered by Focal Point Technology™, that delivers energy at any depth in the skin with pinpoint accuracy, making it ideal for patients with darker skin tones.
